Table 4 Multivariable associations of clinical variables with CKD in high-risk population
Variable | OR (95 % CI) | P-value |
|---|---|---|
Gender | ||
Malea | Referent | |
Female | 1.63 (0.82–3.24) | 0.167 |
Age group | ||
<40a | Referent | |
40–49 | 0.88 (0.07–10.46) | 0.921 |
50–59 | 2.16 (0.24–19.75) | 0.496 |
60–69 | 2.41 (0.27–21.67) | 0.433 |
≥70 | 2.80 (0.30–26.42) | 0.369 |
Condition | ||
HPTa | Referent | |
DM | 1.33 (0.65–2.71) | 0.442 |
DM/HPT | 10.32 (3.43–31.09) | 0.000 |
BMI n (%) | ||
Underweighta | Referent | |
Normal | 0.14 (0.01–1.47) | 0.102 |
Overweight | 0.14 (0.01–1.45) | 0.1 |
Obese | 0.13 (0.01–1.31) | 0.083 |
Duration on medication | ||
<5a | Referent | |
5–10 | 1.01 (0.54–1.87) | 0.989 |
>10 | 8.96 (1.74–46.10) | 0.009 |
Diabetes medication | ||
Non-diabetics | Referent | |
Insulin | 1.10 (0.48–2.55) | 0.818 |
OHA | 0.541 (0.28–1.05) | 0.069 |
Anti-hypertensive medication | ||
Non-hypertensive | Referent | |
ACE-I | 0.55 (0.21–1.45) | 0.225 |
β-blocker | 0.51 (0.22–1.20) | 0.124 |